Manipulating the gut microbiota to maintain health and treat disease

Karen P Scott, Jean-Michel Antoine, Tore Midtvedt, Saskia van Hemert

Research output: Contribution to journalArticle

Abstract

BACKGROUND: The intestinal microbiota composition varies between healthy and diseased individuals for numerous diseases. Although any cause or effect relationship between the alterations in the gut microbiota and disease is not always clear, targeting the intestinal microbiota might offer new possibilities for prevention and/or treatment of disease.

OBJECTIVE: Here we review some examples of manipulating the intestinal microbiota by prebiotics, probiotics, and fecal microbial transplants.

RESULTS: Prebiotics are best known for their ability to increase the number of bifidobacteria. However, specific prebiotics could potentially also stimulate other species they can also stimulate other species associated with health, like Akkermansia muciniphila, Ruminococcus bromii, the Roseburia/Enterococcus rectale group, and Faecalibacterium prausnitzii. Probiotics have beneficial health effects for different diseases and digestive symptoms. These effects can be due to the direct effect of the probiotic bacterium or its products itself, as well as effects of the probiotic on the resident microbiota. Probiotics can influence the microbiota composition as well as the activity of the resident microbiota. Fecal microbial transplants are a drastic intervention in the gut microbiota, aiming for total replacement of one microbiota by another. With numerous successful studies related to antibiotic-associated diarrhea and Clostridium difficile infection, the potential of fecal microbial transplants to treat other diseases like inflammatory bowel disease, irritable bowel syndrome, and metabolic and cardiovascular disorders is under investigation.

CONCLUSIONS: Improved knowledge on the specific role of gut microbiota in prevention and treatment of disease will help more targeted manipulation of the intestinal microbiota. Further studies are necessary to see the (long term) effects for health of these interventions.

Original languageEnglish
Pages (from-to)25877
JournalMicrobial Ecology in Health and Disease
Volume26
DOIs
Publication statusPublished - 2015

Fingerprint

Probiotics
Microbiota
Health
Prebiotics
Ruminococcus
Clostridium Infections
Bifidobacterium
Clostridium difficile
Irritable Bowel Syndrome
Enterococcus
Gastrointestinal Microbiome
Inflammatory Bowel Diseases
Diarrhea
Anti-Bacterial Agents
Bacteria
Therapeutics
Fecal Microbiota Transplantation

Keywords

  • Clostridium difficile
  • fecal microbial transplants
  • inflammatory bowel disease
  • irritable bowel syndrome
  • obesity
  • prebiotics
  • probiotics

Cite this

Manipulating the gut microbiota to maintain health and treat disease. / Scott, Karen P; Antoine, Jean-Michel; Midtvedt, Tore; van Hemert, Saskia.

In: Microbial Ecology in Health and Disease, Vol. 26, 2015, p. 25877.

Research output: Contribution to journalArticle

Scott, Karen P ; Antoine, Jean-Michel ; Midtvedt, Tore ; van Hemert, Saskia. / Manipulating the gut microbiota to maintain health and treat disease. In: Microbial Ecology in Health and Disease. 2015 ; Vol. 26. pp. 25877.
@article{e698a19f633d4466929f82a7c92e269c,
title = "Manipulating the gut microbiota to maintain health and treat disease",
abstract = "BACKGROUND: The intestinal microbiota composition varies between healthy and diseased individuals for numerous diseases. Although any cause or effect relationship between the alterations in the gut microbiota and disease is not always clear, targeting the intestinal microbiota might offer new possibilities for prevention and/or treatment of disease.OBJECTIVE: Here we review some examples of manipulating the intestinal microbiota by prebiotics, probiotics, and fecal microbial transplants.RESULTS: Prebiotics are best known for their ability to increase the number of bifidobacteria. However, specific prebiotics could potentially also stimulate other species they can also stimulate other species associated with health, like Akkermansia muciniphila, Ruminococcus bromii, the Roseburia/Enterococcus rectale group, and Faecalibacterium prausnitzii. Probiotics have beneficial health effects for different diseases and digestive symptoms. These effects can be due to the direct effect of the probiotic bacterium or its products itself, as well as effects of the probiotic on the resident microbiota. Probiotics can influence the microbiota composition as well as the activity of the resident microbiota. Fecal microbial transplants are a drastic intervention in the gut microbiota, aiming for total replacement of one microbiota by another. With numerous successful studies related to antibiotic-associated diarrhea and Clostridium difficile infection, the potential of fecal microbial transplants to treat other diseases like inflammatory bowel disease, irritable bowel syndrome, and metabolic and cardiovascular disorders is under investigation.CONCLUSIONS: Improved knowledge on the specific role of gut microbiota in prevention and treatment of disease will help more targeted manipulation of the intestinal microbiota. Further studies are necessary to see the (long term) effects for health of these interventions.",
keywords = "Clostridium difficile, fecal microbial transplants, inflammatory bowel disease, irritable bowel syndrome, obesity, prebiotics, probiotics",
author = "Scott, {Karen P} and Jean-Michel Antoine and Tore Midtvedt and {van Hemert}, Saskia",
note = "Acknowledgements The authors acknowledge the support of the European Science Foundation (ESF), in the framework of the Research Networking Programme, The European Network for Gastrointestinal Health Research (ENGiHR). The Rowett Institute of Nutrition and Health (KPS) receives support from the Scottish Government (RESAS).",
year = "2015",
doi = "10.3402/mehd.v26.25877",
language = "English",
volume = "26",
pages = "25877",
journal = "Microbial Ecology in Health and Disease",
issn = "0891-060X",
publisher = "Taylor & Francis",

}

TY - JOUR

T1 - Manipulating the gut microbiota to maintain health and treat disease

AU - Scott, Karen P

AU - Antoine, Jean-Michel

AU - Midtvedt, Tore

AU - van Hemert, Saskia

N1 - Acknowledgements The authors acknowledge the support of the European Science Foundation (ESF), in the framework of the Research Networking Programme, The European Network for Gastrointestinal Health Research (ENGiHR). The Rowett Institute of Nutrition and Health (KPS) receives support from the Scottish Government (RESAS).

PY - 2015

Y1 - 2015

N2 - BACKGROUND: The intestinal microbiota composition varies between healthy and diseased individuals for numerous diseases. Although any cause or effect relationship between the alterations in the gut microbiota and disease is not always clear, targeting the intestinal microbiota might offer new possibilities for prevention and/or treatment of disease.OBJECTIVE: Here we review some examples of manipulating the intestinal microbiota by prebiotics, probiotics, and fecal microbial transplants.RESULTS: Prebiotics are best known for their ability to increase the number of bifidobacteria. However, specific prebiotics could potentially also stimulate other species they can also stimulate other species associated with health, like Akkermansia muciniphila, Ruminococcus bromii, the Roseburia/Enterococcus rectale group, and Faecalibacterium prausnitzii. Probiotics have beneficial health effects for different diseases and digestive symptoms. These effects can be due to the direct effect of the probiotic bacterium or its products itself, as well as effects of the probiotic on the resident microbiota. Probiotics can influence the microbiota composition as well as the activity of the resident microbiota. Fecal microbial transplants are a drastic intervention in the gut microbiota, aiming for total replacement of one microbiota by another. With numerous successful studies related to antibiotic-associated diarrhea and Clostridium difficile infection, the potential of fecal microbial transplants to treat other diseases like inflammatory bowel disease, irritable bowel syndrome, and metabolic and cardiovascular disorders is under investigation.CONCLUSIONS: Improved knowledge on the specific role of gut microbiota in prevention and treatment of disease will help more targeted manipulation of the intestinal microbiota. Further studies are necessary to see the (long term) effects for health of these interventions.

AB - BACKGROUND: The intestinal microbiota composition varies between healthy and diseased individuals for numerous diseases. Although any cause or effect relationship between the alterations in the gut microbiota and disease is not always clear, targeting the intestinal microbiota might offer new possibilities for prevention and/or treatment of disease.OBJECTIVE: Here we review some examples of manipulating the intestinal microbiota by prebiotics, probiotics, and fecal microbial transplants.RESULTS: Prebiotics are best known for their ability to increase the number of bifidobacteria. However, specific prebiotics could potentially also stimulate other species they can also stimulate other species associated with health, like Akkermansia muciniphila, Ruminococcus bromii, the Roseburia/Enterococcus rectale group, and Faecalibacterium prausnitzii. Probiotics have beneficial health effects for different diseases and digestive symptoms. These effects can be due to the direct effect of the probiotic bacterium or its products itself, as well as effects of the probiotic on the resident microbiota. Probiotics can influence the microbiota composition as well as the activity of the resident microbiota. Fecal microbial transplants are a drastic intervention in the gut microbiota, aiming for total replacement of one microbiota by another. With numerous successful studies related to antibiotic-associated diarrhea and Clostridium difficile infection, the potential of fecal microbial transplants to treat other diseases like inflammatory bowel disease, irritable bowel syndrome, and metabolic and cardiovascular disorders is under investigation.CONCLUSIONS: Improved knowledge on the specific role of gut microbiota in prevention and treatment of disease will help more targeted manipulation of the intestinal microbiota. Further studies are necessary to see the (long term) effects for health of these interventions.

KW - Clostridium difficile

KW - fecal microbial transplants

KW - inflammatory bowel disease

KW - irritable bowel syndrome

KW - obesity

KW - prebiotics

KW - probiotics

U2 - 10.3402/mehd.v26.25877

DO - 10.3402/mehd.v26.25877

M3 - Article

VL - 26

SP - 25877

JO - Microbial Ecology in Health and Disease

JF - Microbial Ecology in Health and Disease

SN - 0891-060X

ER -